Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury.
Acute Kidney Injury
/ epidemiology
Adolescent
Age Factors
Biomarkers
Child
Child, Preschool
Female
Humans
Infant
Intensive Care Units, Pediatric
/ statistics & numerical data
Interleukin-6
/ blood
Male
Prospective Studies
Racial Groups
Respiration, Artificial
/ statistics & numerical data
Respiratory Distress Syndrome
/ epidemiology
Risk Factors
Severity of Illness Index
Sex Factors
Water-Electrolyte Balance
/ physiology
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
24
1
2019
medline:
12
5
2020
entrez:
24
1
2019
Statut:
ppublish
Résumé
As acute kidney injury and elevated cumulative fluid balance commonly co-occur in pediatric acute respiratory distress syndrome, we aimed to identify risk factors for their development and evaluate their independent relationships with mortality. We hypothesized that acute kidney injury and elevated cumulative fluid balance would be associated with markers of inflammation and that children with elevated cumulative fluid balance and concomitant acute kidney injury would have worse outcomes than other children. Prospective observational study using the pediatric Risk, Injury, Failure, Loss, End-Stage acute kidney injury classification. Five academic PICUs. Two-hundred sixty patients 1 month to 18 years old meeting the Berlin definition of acute respiratory distress syndrome between 2008 and 2014. None. PICU mortality was 13% (34/260). Relative to survivors, nonsurvivors had greater cumulative fluid balance on day 3 of acute respiratory distress syndrome (+90.1 mL/kg; interquartile range 26.6-161.7 vs +44.9 mL/kg; interquartile range 10.0-111.3; p = 0.008) and also had higher prevalence of acute kidney injury on day 3 of acute respiratory distress syndrome (50% vs 23%; p = 0.001). On stratified analysis, greater cumulative fluid balance on day 3 of acute respiratory distress syndrome was associated with mortality among patients with concomitant acute kidney injury (+111.5 mL/kg for nonsurvivors; interquartile range 82.6-236.8 vs +58.5 mL/kg for survivors; interquartile range 0.9-176.2; p = 0.041) but not among patients without acute kidney injury (p = 0.308). The presence of acute kidney injury on acute respiratory distress syndrome day 3 was associated with mortality among patients with positive cumulative fluid balance (29.1% vs 10.4% mortality; p = 0.001) but not among patients with even or negative cumulative fluid balance (p = 0.430). Day 1 plasma interleukin-6 levels were associated with the development of day 3 positive cumulative fluid balance, day 3 acute kidney injury, and PICU mortality and the association between elevated day 1 interleukin-6 and PICU mortality was partially mediated by the interval development of day 3 positive cumulative fluid balance and day 3 acute kidney injury (p < 0.001). In pediatric acute respiratory distress syndrome, elevated cumulative fluid balance on day 3 of acute respiratory distress syndrome is associated with mortality specifically in patients with concomitant acute kidney injury. Plasma interleukin-6 levels are associated with the development of positive cumulative fluid balance and acute kidney injury, suggesting a potential mechanism by which inflammation might predispose to mortality.
Identifiants
pubmed: 30672838
doi: 10.1097/PCC.0000000000001845
pmc: PMC6454886
mid: NIHMS1515998
doi:
Substances chimiques
Biomarkers
0
Interleukin-6
0
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-331Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL085526
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114484
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD000850
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK098233
Pays : United States
Organisme : NHLBI NIH HHS
ID : R37 HL051856
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK113381
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD049303
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL110969
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK101507
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL108713
Pays : United States
Références
BMC Pulm Med. 2015 Aug 23;15:98
pubmed: 26298866
Chest. 1995 Apr;107(4):1062-73
pubmed: 7705118
JAMA Pediatr. 2018 Mar 1;172(3):257-268
pubmed: 29356810
PLoS One. 2016 Jul 28;11(7):e0160093
pubmed: 27467522
Pediatr Crit Care Med. 2013 May;14(4):e189-95
pubmed: 23439463
Crit Care Med. 2017 May;45(5):858-866
pubmed: 28248715
Ann Intensive Care. 2014 Feb 18;4(1):4
pubmed: 24533450
Chest. 2016 Jul;150(1):102-11
pubmed: 27018313
Am J Med. 1981 Feb;70(2):227-33
pubmed: 7468609
Pediatr Crit Care Med. 2012 May;13(3):253-8
pubmed: 21760565
Crit Care. 2014 Oct 13;18(5):538
pubmed: 25497357
Am J Kidney Dis. 2010 Feb;55(2):316-25
pubmed: 20042260
Nat Rev Nephrol. 2010 Jul;6(7):393-4
pubmed: 20585319
Adv Clin Exp Med. 2013 May-Jun;22(3):377-86
pubmed: 23828679
Intensive Care Med. 2008 Sep;34(9):1713-7
pubmed: 18521567
J Trauma. 1977 Sep;17(9):667-76
pubmed: 894757
Arch Dis Child. 2005 Sep;90(9):965-71
pubmed: 16113134
J Am Soc Nephrol. 2008 Jun;19(6):1106-15
pubmed: 18337485
Intensive Care Med. 2014 Oct;40(10):1536-44
pubmed: 25023526
Crit Care Med. 2007 Dec;35(12):2755-61
pubmed: 18074478
Pediatr Nephrol. 2015 Sep;30(9):1519-27
pubmed: 25877915
Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1993-9
pubmed: 15964925
Crit Care Med. 2012 Oct;40(10):2883-9
pubmed: 22824936
Crit Care Med. 2013 Feb;41(2):472-80
pubmed: 23263578
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43
pubmed: 19820136
Pediatr Crit Care Med. 2015 Jun;16(5 Suppl 1):S118-31
pubmed: 26035362
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Chest. 2005 Nov;128(5):3098-108
pubmed: 16304249
N Engl J Med. 2006 Jun 15;354(24):2564-75
pubmed: 16714767
Pediatr Crit Care Med. 2013 Mar;14(3):261-7
pubmed: 23392372
Ann Intensive Care. 2012 Jul 5;2 Suppl 1:S15
pubmed: 22873416
Crit Care Med. 2004 Aug;32(8):1771-6
pubmed: 15286557
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
Am J Respir Crit Care Med. 2017 Feb 1;195(3):331-338
pubmed: 27513822
Crit Care Res Pract. 2011;2011:854142
pubmed: 21687578
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):554-61
pubmed: 25649155
BMC Pediatr. 2018 Jun 26;18(1):207
pubmed: 29945586
Pediatrics. 2001 Jun;107(6):1309-12
pubmed: 11389248
Crit Care Med. 1996 May;24(5):743-52
pubmed: 8706448
Pediatr Crit Care Med. 2016 Oct;17(10):907-916
pubmed: 27487912
Ann Intensive Care. 2015 Dec;5(1):38
pubmed: 26546321
Pediatr Crit Care Med. 2013 Sep;14(7):666-72
pubmed: 23925143
Pediatr Nephrol. 2004 Jan;19(1):91-5
pubmed: 14634863
Pediatr Nephrol. 2012 Mar;27(3):363-73
pubmed: 21713524
J Crit Care. 2009 Sep;24(3):394-400
pubmed: 19327959
Physiol Rep. 2014 Jul 22;2(7):
pubmed: 25052489
Lancet Respir Med. 2014 Aug;2(8):611-20
pubmed: 24853585
Clin J Am Soc Nephrol. 2008 Jul;3(4):948-54
pubmed: 18417742
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Pediatr Crit Care Med. 2015 Jun;16(5 Suppl 1):S6-22
pubmed: 26035365
Crit Care Med. 2011 Dec;39(12):2665-71
pubmed: 21785346
Kidney Int. 2007 May;71(10):1028-35
pubmed: 17396113
Pediatr Nephrol. 2013 Mar;28(3):485-92
pubmed: 23179195
J Clin Invest. 1999 Aug;104(4):495-502
pubmed: 10449441